TGFB1 and acute myeloid leukemia: However, the opposite effect of TGFβ has also been reported; for example, TGFβ derived from activated bone marrow microenvironment enhanced the aggressiveness of human MLL-AF9 oncogene-induced AML in mouse transplantation models [32].